Volume 36, Issue 10, Page 33 (October 2008)
44 of 61
PREVIEW
FULL TEXT
FULL-TEXT PDF (84 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
MADRID — Rasagiline may have a disease-modifying effect for patients with Parkinson's, delaying the progression of symptoms early in the disease at least in the short term, a new placebo-controlled trial has found.
PII: S0270-6644(08)70721-5
doi:10.1016/S0270-6644(08)70721-5
© 2008 Elsevier Inc. All rights reserved.
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.